Since its creation in 1987, the Centre de recherche de l'Institut universitaire en santé mentale de Québec (CRIUSMQ) endeavors to research for the best means to alleviate the suffering of patients with nervous system diseases. Researchers are pursuing the mission to generate new and growing knowledge concerning the causes and treatments of neurological and psychiatric disorders in children, adults and the elderly, in a high tech center focused on the neuron and the brain.
Marc-André Roy, M D, M Sc, FRCP
Chercheur - Neurosciences cliniques et cognitives
Centre de recherche de l'institut universitaire en santé mentale de Québec
Schizophrénie et comorbidités


As part of the joint program CQDM / Alsace BioValley, the project submitted by Photon Etc., Rhenovia and the Neurophotonics center has been granted.
Development and validation of two synergistic platforms based on imaging and biosimulation to visualize the action of drug candidates at the subcellular and molecular levels.
Québec: Sébastien Blais-Ouellette (Photon Etc.) and Paul De Koninck (Université Laval and Neurophotonics center – Centre de recherche Université Laval Robert-Giffard)
Alsace: Serge Bischoff (Rhenovia Pharma)
$700,000 over 3 years (for the research being performed in Québec)


From September 10 to 14, at the Québec City Convention Center, will be held the 4th International World Sleep Congress and 5th Conference of the Canadian Sleep Society.
This conference is chaired by Dr. Charles M. Morin, Ph.D.
For more information,
visit: www.wasmonline.org